Research Groups and R&D Platforms: Diagnostics, Personalized medicine

Research Group:
Systems Medicine

Matej Oresic
matej.oresic[at]utu.fi

Turku Bioscience,
University of Turku

Matej Oresic

Systems Medicine

Assay development, Autoimmune diseases, Bioinformatics, Biomarker, Diabetes, Diagnostics, Metabolic diseases, Metabolomics, Molecular diagnostics, Obesity, Personalized medicine, Systems Biology

Research Group:
Cell fate – from molecular understanding to control

Cecilia Sahlgren
cecilia.sahlgren[at]abo.fi, cecilia.sahlgren[at]bioscience.fi

Turku Bioscience and
Faculty of Science and Engineering,
Åbo Aakdemi University

Cecilia Sahlgren

Cell fate

The Cell Fate Lab

Atomic-force microscopy, Basic research, Biochemistry, Biomarker, Biotechnology, Breast cancer, Cancer, Cardiovascular diseases, Data mining, Developmental disorders, Diagnostics, Disease models, Drug delivery, Drug target, Imaging, Imaging software, In Vivo Diagnostics, Molecular Cell Biology, Molecular modelling, Personalized medicine, PET, Proteomics, Receptor, Signaling, Super-resolution imaging, Target discovery

Research Group:
Alpha2-Adrenoceptors as targets for drug development

Mika Scheinin
mschein[at]utu.fi

University of Turku, Turku University Hospital and CRST Oy

Mika Scheinin

Clinical Research Services Turku

Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery

Research Group:
Genetic predisposition to cancer

Johanna Schleutker
Johanna.Schleutker[at]utu.fi

Institute of Biomedicine,
University of Turku

Johanna Schleutker

Genetic Predisposition to Prostate Cancer

Antibodies, Assay development, Bioinformatics, Biomarker, Biomedicine, Biotechnology, Breast cancer, Cancer, Clinical Medicine, Data mining, Diagnostics, Epidemiology, Genetics, Genomics, In Vitro Diagnostics, Inherited diseases, Machine learning, Molecular Biology, Molecular diagnostics, Next-generation sequencing, Personalized medicine, Point of care, Prostate cancer, Screening

Research Group:
Toll-like receptor 9 in cancer

Johanna Tuomela
jomitu[at]utu.fi

Institute of Biomedicine,
University of Turku

Johanna Tuomela

Basic research, Biomedicine, Breast cancer, Cancer, Diagnostics, Disease models, Drug target, Inflammation, Personalized medicine, Prostate cancer, Squamous cell carcinoma, Target discovery

Research Group:
Cancer Cell Signaling

Jukka Westermarck
jukwes[at]utu.fi

Turku Bioscience and Institute of Biomedicine,
University of Turku

Jukka Westermarck

Cancer Cell Signaling

Assay development, Basic research, Biochemistry, Biomarker, Biomedicine, Breast cancer, Cancer, Colorectal cancer, Data mining, Diagnostics, Disease models, Drug delivery, Genomics, Lung cancer, Molecular Biology, Molecular Cell Biology, Nanoparticles, Next-generation sequencing, Pathology, Personalized medicine, Prostate cancer, Proteomics, Receptor, Screening, Signaling, Squamous cell carcinoma, Systems Biology, Target discovery, X-ray crystallography